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TPR Subunits of the Anaphase-Promoting Complex
Mediate Binding to the Activator Protein CDH1
These chains act as recognition signals that target the
substrate proteins for proteolysis by the 26S protea-
some (reviewed in [3]).
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Research Institute of Molecular Pathology (IMP) The APC is an unusually complex E3 composed of at
Dr. Bohr-Gasse 7 least 11 subunits in vertebrates and 13 subunits in yeast
A-1030 Vienna [4, 5]. Like many other ubiquitin ligases, the APC con-
Austria tains a small RING finger subunit [4, 6]. This protein,
called APC11, is sufficient to support the assembly of
multiubiquitin chains in the presence of the E2 enzyme
Summary UBC4, although these reactions show reduced sub-
strate specificity [4, 7]. APC11 interacts with a cullin
Background: Chromosome segregation and mitotic exit domain in APC2 [8], and recombinant APC11 monomers
depend on activation of the anaphase-promoting com- and APC11/APC2 heterodimers can bind to E2 enzymes
plex (APC) by the substrate adaptor proteins CDC20 [7, 8]. Similar pairs of cullin and RING finger proteins
and CDH1. The APC is a ubiquitin ligase composed of also form the core of the ubiquitin ligase complexes SCF
at least 11 subunits. The interaction of APC2 and APC11 and CBC [2]. Despite this central role in ubiquitination
with E2 enzymes is sufficient for ubiquitination reac- reactions, it remains unclear how these proteins pro-
tions, but the functions of most other subunits are un- mote ubiquitin transfer.
known. The function of other APC subunits is less well under-
Results: We have biochemically characterized sub- stood. The crystal structure of the small subunit APC10/
complexes of the human APC. One subcomplex, con- Doc1 implies that this protein binds a yet unidentified
taining APC2/11, APC1, APC4, and APC5, can assemble ligand [9, 10]. Budding yeast Doc1 has furthermore been
multiubiquitin chains but is unable to bind CDH1 and to reported to be required for the processivity of APC-
ubiquitinate substrates. The other subcomplex contains mediated ubiquitination reactions [11] and for the bind-
all known APC subunits except APC2/11. This subcom- ing of substrates [12]. Human APC10 can bind to APC3/
plex can recruit CDH1 but fails to support any ubiquitina- Cdc27 [9], one of four tetratrico peptide repeat (TPR)
tion reaction. In vitro, the C termini of CDC20 and CDH1 proteins found in vertebrate APC. TPR domains are
bind to the closely related TPR subunits APC3 and thought to mediate protein-protein interactions [13–15]
APC7. Homology modeling predicts that these proteins and were discovered in the first identified APC subunits
are similar in structure to the peroxisomal import recep- [13, 16, 17]. Although TPR subunits of the APC are es-
tor PEX5, which binds cargo proteins via their C termini. sential for viability in yeast [13, 18] and represent the
APC activation by CDH1 depends on a conserved largest group of structurally related proteins within the
C-terminal motif that is also found in CDC20 and APC10. APC, their precise role has remained unknown.
Conclusions: APC1, APC4, and APC5 may connect Despite this already complex architecture, the APC
APC2/11 with TPR subunits. TPR domains in APC3 and still requires additional activator proteins for substrate
APC7 recruit CDH1 to the APC and may thereby bring ubiquitination (reviewed by [1, 2]). Mitotic phosphoryla-
substrates into close proximity of APC2/11 and E2 en- tion of multiple APC subunits allows association with
zymes. In analogy to PEX5, the different TPR subunits
the activator CDC20 (also known as p55CDC, Fizzy, or
of the APC might function as receptors that interact
Slp1). In metaphase and anaphase, APCCDC20 ubiquiti-
with the C termini of regulatory proteins such as CDH1,
nates B-type cyclins and thereby inactivates cyclin-
CDC20, and APC10.
dependent kinase 1 (CDK1). This CDK1 inactivation in
turn leads to activation of a second, CDC20-related APCIntroduction
activator called CDH1 (a.k.a. Fizzy-related, Hct1, Ste9,
or Srw1). CDH1 interaction with the APC is restricted toThe anaphase-promoting complex or cyclosome (APC)
late mitosis and G1/G0, since phosphorylation of CDH1is a ubiquitin ligase (E3) that controls important transi-
prevents the assembly of APCCDH1 during S, G2, andtions in mitosis and helps to establish and maintain the
early mitosis.G1 phase of the eukaryotic cell cycle. The main APC
CDC20 and CDH1 activate the APC in a substrate-targets in mitosis are the anaphase inhibitor securin,
specific manner [19] that depends on the presence ofwhose destruction promotes sister chromatid separa-
sequence elements called destruction and KEN boxestion, and B-type cyclins, which have to be degraded to
in APCCDC20 and APCCDH1 substrates, respectively [20, 21].allow exit from mitosis (reviewed in [1, 2]). The APC
CDC20 and CDH1 can furthermore bind to APC sub-initiates these proteolytic reactions by mediating the
strates (reviewed in [22]) and are required for the associ-transfer of activated ubiquitin residues from ubiquitin-
ation of substrates with the APC [12]. These observa-conjugating (E2) enzymes to substrates, and this trans-
tions imply that CDC20 and CDH1 are adaptor proteinsfer results in the formation of multiubiquitin chains.
that recruit substrates to the APC. In budding yeast
Cdh1, a conserved sequence element called the C box*Correspondence: peters@imp.univie.ac.at
1These authors contributed equally to this work. is required for Cdh1 binding to the APC [23], but it is
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unknown to which APC subunits the activator proteins
bind.
To understand how the APC mediates ubiquitination
reactions, what the function of its individual subunits is,
and how activator proteins interact with the APC, it
would be desirable to reconstitute the complex either
partly or completely from recombinant subunits. How-
ever, with the exception of APC2–APC11 heterodimers
[8], it has been impossible to assemble APC subcom-
plexes to date. We have therefore pursued a reverse
strategy and have isolated subcomplexes derived from
native human APC and characterized their properties.
Combined with structural predictions, our data suggest
roles for TPR subunits as receptors for the activators
CDH1/CDC20.
Results
The Catalytic Subunits APC2 and APC11 Can Be
Reversibly Dissociated from Holo-APC
To identify APC subcomplexes, we searched for condi-
tions that dissociate individual subunits from purified
native human APC. Based on previously developed im-
munopurification methods [24], we treated human APC
bound to APC3 antibody beads with various buffer con-
ditions and found that extensive washing with a high-
salt sodium phosphate buffer of pH 6.5 greatly reduced
the amounts of APC2 and APC11 in the immunoprecipi-
tates. All other APC subunits remained bound to the
antibody beads, only the levels of APC10 were slightly
reduced. Lowering the pH below 6.3 caused dissociation
of all subunits from the antibody beads, presumably
because the antibody-antigen interaction was weak-
Figure 1. APC2 and APC11 Can Be Dissociated from the APCened (data not shown). To purify APC2/APC11-depleted
(A) A silver-stained gel (left) and Western blot (right) of APC immuno-complexes, we eluted them with the antigenic APC3
precipitates after high-salt washes under different pH conditions.
peptide, depleted residual complexes still containing (B) CDH1 binding assay. Holo-APC and 2/11-APC were incubated
APC2 with APC2 antibodies, and finally reimmunopre- with buffer or recombinant HisHA-CDH1 and were probed with
cipitated with APC4 antibodies. Silver staining and im- CDH1 antibodies for the presence of endogenous (lower band) and
recombinant (upper band) CDH1.munoblotting showed that the remaining APC subunits
(C) An in vitro ubiquitination assay with holo-APC and 2/11-APC.were still part of an intact complex in which APC2 and
Recombinant securin used as substrate was detected by WesternAPC11 could not be detected (Figure 1A). We refer to
blotting.
this subcomplex as 2/11-APC. To confirm that 2/11-
APC represents an intact macromolecular assembly and
not merely a protein aggregate, we analyzed the APC2- plexes (data not shown). We subsequently analyzed
holo-APC and 2/11-APC for ubiquitination activity to-depleted eluate by sucrose density gradient centrifuga-
tion. The remaining subunits of 2/11-APC cosedi- ward the substrate securin in the presence of ATP,
CDH1, E1, and the E2 enzymes UBC4 and UBCx.mented as a peak of approximately 22S, verifying that
they were present in a discrete APC subcomplex (see Whereas holo-APC efficiently ubiquitinated securin un-
der these conditions, 2/11-APC was completely inac-Figure S1 in the Supplemental Data available with this
article online). Holo-APC also sediments with an S value tive (Figure 1C).
The lack of activity associated with 2/11-APC couldof 22 ([24], Figure S1), indicating that the loss of APC2
and APC11 does not grossly change the mass and shape have been caused by the loss of APC2 and APC11 or
by damage to other subunits during the mildly acidicof the remaining complex.
To analyze which functional properties 2/11-APC re- pH treatment. To distinguish between these possibilit-
ies, we tested if active holo-APC could be reconstitutedtains, we first tested binding to CDH1. Both holo-APC
and 2/11-APC could be loaded with comparable from purified 2/11-APC and APC2/APC11 complexes
generated in baculovirus-infected insect cells. Figureamounts of purified recombinant CDH1 (Figure 1B); this
finding implies that APC2 and APC11 are dispensable 2A shows that coexpressed APC2 and APC11 bound to
the depleted complex, whereas little or no associationfor CDH1 binding. This notion was further supported by
the observations that 2/11-APC also contained some was seen with singly expressed APC2 and APC11, even
when a mixture of both proteins was incubated with 2/endogenous CDH1 (Figure 1B), and that CDH1 could
neither bind to nor activate recombinant APC2/11 com- 11-APC. This finding is consistent with the observation
Molecular Interactions between the APC and CDH1
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This reconstitution of functional holo-APC from 2/
11-APC and recombinant APC2/11 implies that 2/11-
APC is not irreversibly damaged by the low-pH treat-
ment, and the lack of ubiquitination activity thus appears
to be a direct consequence of the loss of APC2 and
APC11. APC2 and APC11 are therefore strictly required
for the ubiquitination activity of the APC but are dispens-
able for CDH1 binding.
APC1, 2, 4, 5, and 11 Form a Stable Subcomplex
We discovered a second APC subcomplex through frac-
tionation of extracts from logarithmically grown HeLa
cells on a Source Q15 anion exchange column. Immu-
noblot analysis of individual fractions showed that holo-
APC containing all 11 subunits eluted in a sharp peak
at around 450 mM KCl, whereas the TPR proteins APC3,
APC6, and APC7 were also found in other fractions,
especially in late fractions eluted with higher ionic
strength (see Figure S2 in the Supplemental Data).
Whereas several APC subunits (e.g., APC10) were only
detected in the holo-APC fraction, APC2 and APC11
appeared in a distinct second peak already eluting at
350 mM KCl (Figure S2 and data not shown). To analyze
Figure 2. Reconstitution of Active, CDH1-Responsive Holo-APC if these proteins were part of a distinct subcomplex
from 2/11-APC and Recombinant APC2 and APC11
or had simply dissociated from holo-APC as individual
(A) A Western blot of 2/11-APC bound to APC4 beads after incu- proteins, we immunoprecipitated APC2 from the 350
bation with insect cell lysates containing the indicated recombinant
mM KCl fraction. Subsequent immunoblotting detectedproteins.
APC1, APC2, APC4, APC5, and APC11 without signifi-(B) An in vitro ubiquitination assay with recombinant GST-APC11/
APC2 subcomplexes bound to glutathione sepharose and securin cant contamination by any other subunit (Figure 3A). To
in the presence of either UBC4 or UBCx. confirm that they form an independent subcomplex, we
(C) An in vitro securin ubiquitination assay with 2/11-APC reconsti- depleted residual holo-APC from the 350 mM fractions
tuted with the indicated insect cell lysates in the presence of UBCx by using APC3 antibodies and subsequently purified the
and recombinant CDH1.
subcomplex with antibodies against APC2, APC4, or(D) An in vitro ubiquitination assay with 2/11-APC reconstituted
APC5. All three antibodies immunoprecipitated thewith the indicated insect cell lysates in the absence and presence
of CDH1. same five subunits in roughly stoichiometric amounts
(Figure 3B and data not shown). In an additional purifica-
tion step, these subunits could also be eluted from APC4
antibody beads by the antigenic peptide and could sub-of Tang et al. [8] that APC2 and APC11 only interact upon
coexpression, and further it implies that this interaction sequently be reimmunoprecipitated with APC5 antibod-
ies (Figure 3C). These data indicate that APC1, APC2,either creates a common interface for APC association
or is essential for proper folding and structural integrity APC4, APC5, and APC11 form a stable subcomplex that,
based on its elution properties from the Q column, weof these two subunits.
To discriminate a functional interaction from unspe- refer to as Q350-APC.
We presently do not know if Q350-APC was generatedcific binding, we examined the ubiquitination activity
of the reconstituted complex. Ubiquitination reactions during the fractionation, or if it represents a physiologi-
cal subcomplex, for example, an assembly intermediate.mediated by holo-APC can be supported by either one
of the E2 enzymes UBC4 and UBCx in vitro [17, 25], but Nevertheless, its apparent stability gave us the opportu-
nity to investigate its properties further. In vitro ubiquiti-in our hands, reactions mediated by recombinant APC11
or APC2/11 are only supported efficiently by UBC4 and nation activity of Q350-APC toward securin was close to
that of control reactions containing no E3, despite thenot by UBCx ([4]; Figure 2B). We therefore used the
ability of UBCx to support ubiquitination reactions to presence of APC2/11 (Figure 3D). This was, however,
not due to loss of APC2/11 activity, since Q350-APC wasdiscriminate between activity mediated by APC2/11 or
by holo-APC. As shown in Figure 2C, 2/11-APC that capable of multiubiquitin chain assembly (Figure 3E).
We also compared the ability of holo-APC and Q350-had bound to coexpressed APC2 and APC11 indeed
regained the ability to ubiquitinate securin in the pres- APC to recruit the E2 enzyme UBCx. After incubation
of immunoprecipitated complexes with crosslinker-ence of UBCx, whereas singly expressed APC2 and/or
APC11 could not reactivate 2/11-APC. Furthermore, modified UBCx and subsequent immunoblotting with
anti-UBCx antibodies, only a few major bands, whosethe observed activity was dependent on the activator
CDH1 (Figure 2D). Since ubiquitination reactions medi- sizes were consistent with modification of APC2, were
observed (Figure 3F). Reprobing with antibodies againstated by APC11 or APC2/11 cannot be stimulated by
recombinant CDH1 ([4, 8]; data not shown), this con- APC2 (Figure 3F) and other subunits (data not shown)
confirmed that UBCx was specifically crosslinked tofirmed that active holo-APC had been reconstituted.
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Figure 3. A Subcomplex Consisting of APC1, 2, 4, 5, and 11 Elutes Separately from Holo-APC from an Anion Exchange Resin
(A) APC2 IPs from the indicated elution fractions were separated by SDS-PAGE and were visualized by Western blotting.
(B) APC4 IP after predepletion of fraction 350 with APC3 antibodies. Samples were separated by SDS-PAGE and were visualized by silver
staining.
(C) Silver staining of a parallel sample after peptide elution from the APC4 antibody beads and re-IP with APC5 antibodies.
(D) An in vitro ubiquitination assay with holo-APC or Q350-APC and recombinant securin as substrate.
(E) The Western blot shown in (D) was reprobed with antibodies against ubiquitin. The asterisks denote crossreactions with the antibody used
for IP.
(F) Crosslinking of UBCx to holo-APC (left) and Q350-APC (right). Isolated complexes were incubated with modified UBCx and were analyzed
by immunoblotting against UBCx and APC2.
(G) CDH1 binding assay. IPs of holo-APC or Q350-APC were incubated with recombinant HisHA-tagged CDH1 and were immunoblotted for
the presence of endogenous and recombinant CDH1.
APC2 in holo-APC as well as in Q350-APC; this finding and the inability to interact with CDH1, two proteins
implicated in substrate binding [12, 22].further corroborates the notion that Q350-APC is not defi-
cient in recruitment of E2 enzymes carrying activated
ubiquitin. This implies that the deficiency to ubiquitinate The TPR Subunits APC3 and APC7 Bind the C
Termini of CDH1 and CDC20securin might be a direct consequence of the absence
of substrate specificity factors. Consistent with this hy- To understand APC activation, it is important to map the
molecular interactions between the activators CDC20/pothesis, we could not load recombinant CDH1 onto
Q350-APC, whereas APC from the 450 mM KCl fractions CDH1 and APC subunits. Our analysis of 2/11-APC
and Q350-APC revealed that APC2 and APC11 are dis-bound both endogenous and recombinant CDH1 (Fig-
ure 3G). pensable for CDH1 binding, and that APC1, APC2,
APC4, APC5, and APC11 are not sufficient. This leavesWe conclude that Q350-APC can interact with E2 en-
zymes and assemble multiubiquitin chains but cannot CDC26, APC10, and the TPR proteins APC3, APC6,
APC7, and APC8 as possible CDH1 receptors. Sinceconjugate these chains to substrates. This deficiency is
possibly due to a failure in substrate recruitment and multiple TPRs are present in several adaptor proteins
like the cochaperone Hop/Sti1 or the peroxisomal tar-may be a direct consequence of the absence of APC10
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geting signal receptor PEX5 [15], we inspected APC’s
TPR subunits closer by using a computational approach.
Employing a heterogeneous selection of the best-per-
forming structure prediction programs, the TPR do-
mains in APC3, APC6, APC7, and APC8 were identified
by a consensus as being closely related to the TPR
region in PEX5 (see Table S1 in the Supplemental Data).
Substrate binding of PEX5 involves an interaction of its
TPRs with a conserved pentapeptide signal at the C
terminus of the substrates [26, 27]. Using the Swiss-
PDB viewer modeling environment [28], we threaded
APC3’s TPR region onto the backbone of the PEX5
structure (protein data bank id 1FCH, [26]) according to
prediction, and we identified nine TPRs (instead of seven
in PEX5) within residues 499–824. The four first and the
four last TPRs are predicted to form two halves that are
connected by TPR5 as a hinge (Figure 4A). This model
suggested that TPR domains in the APC might form
receptors for C-terminal peptide motifs. Consistent with
this hypothesis, we have previously shown that APC3
interacts with APC10 through APC10’s extended C ter-
minus [9]. When we fitted APC10’s C-terminal pentapep-
tide, YRSIR, into the structural model instead of PEX5’s
cognate PTS1 peptide (Figure 4A), we noted that this
C-terminal motif, especially the ultimate IR residues,
is conserved not only between APC10 orthologs from
different species, but also among the APC activators of
the CDC20/CDH1 family (Figure 4B). This remarkable
conservation in several proteins in the APC context pro-
posed an important, possibly common, functional role
for this motif.
To test if APC3 interacts with the C termini of CDH1
and its related activator CDC20, we incubated insect
cell lysates containing recombinantly expressed APC3
with synthetic peptides coupled to a matrix through their
N terminus. About 10% of input APC3 bound to the
C-terminal peptide of CDC20, and even stronger binding
to a CDH1 C-terminal peptide was observed (Figure 5A).
This interaction was specific, since APC3 did not bind
to a control peptide, and recombinant APC5 interacted
with neither the CDC20 nor the CDH1 peptide (Figure
5A). We next tested the other three TPR subunits and
found that APC8 did not bind either peptide (Figure 5A).
Likewise, binding of APC6 to the C-terminal peptides
was weak and comparable to binding to a control pep-
Figure 4. A Putative Interaction Module between TPR Subunits and
tide (Figure 5A). APC7, on the other hand, interacted APC Activators
strongly with the CDH1 C terminus and moderately with
(A) A three-dimensional model of the TPR domain of APC3, based
CDC20’s C terminus (Figure 5A), in a manner very similar on predicted structural homologies to PEX5. Individual TPRs are
to APC3. We subsequently used APC7 to narrow down depicted in different colors. The PTS1 peptide crystallized with PEX5
the region responsible for interaction. While an APC7 has been replaced by the C-terminal pentapeptide of APC10
(YRSIR), which is known to interact with APC3.fragment containing the N-terminal 297 amino acids did
(B) Alignment of the C termini of APC10, CDC20, and CDH1 or-not exhibit binding, the C-terminal part (amino acids
thologs, as well as the meiotic activators Ama1, Mfr1, and Cortex.298–565) comprising the block of TPRs was strongly
The coloring of individual residues is based on physical propensities
enriched on the peptide matrix (see Figure S3 in the according to CLUSTAL_X. Organisms: Homo sapiens, Hs; Mus mus-
Supplemental Data). These data indicate that the TPR culus, Mm; Xenopus laevis, Xl; Drosophila melanogaster, Dm;
domain is sufficient for interaction with IR tail peptides. Caenorhabditis elegans, Ce; Saccharomyces cerevisiae, Sc; Arabi-
dopsis thaliana, At; Schizosaccharomyces pombe, Sp. GenInfoIn order to exclude any nonspecific effects caused by
numbers: 6463666, 20885472, 27505933 (EST, 2 translation),incorrect folding of recombinantly expressed proteins,
28573741, 17559738, 6321197, 18398701; 4323528, 8885513,we searched for an alternative source of APC subunits
3298595, 17137788, 17537825, 461700, 15240985; 7705377,in our peptide binding assays. As described above, late- 13879284, 2326943, 2326419, 17538129, 6321435, 22328875,
eluting fractions from the Source 15Q anion exchange 14486175, 26396380, 30172925.
column contained considerable amounts of the TPR
subunits APC3, APC6, and APC7, while most other sub-
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Figure 5. The TPR Subunits APC3 and APC7 Mediate APC Interac-
tions with C-Terminal IR Motifs
(A) Matrix-coupled C-terminal peptides were incubated with insect
cell lysates containing recombinant APC subunits. 10% of input (In),
supernatant (S), and 100% of bound material (B) were analyzed by
Western blot.
Figure 6. C-Terminal CDH1/CDC20 Peptides Containing the IR Mo-(B) Late-eluting Q column fractions (fractions 14–16) containing
tif Inhibit CDH1 Binding and APC Activationmainly TPR subunits were used as input in peptide binding assays.
(C) Fractions containing holo-APC were used as input in the de- (A) An in vitro ubiquitination assay. APC IPs were incubated with
scribed peptide binding assay. recombinant CDH1 in the presence or absence of different peptides,
washed, and used in ubiquitination assays with [125I]-labeled cyclin
B as substrate.
(B) CDH1 binding assay. APC IPs treated as in (A) were analyzedunits were largely absent (Figure S2 and data not
by quantitative Western blotting with [125I]-labeled secondary anti-shown). Although these TPR subunits can still be par-
bodies.
tially coprecipitated, they do not seem to be part of
stoichiometric complexes (data not shown). As seen in
Figure 5B, endogenous APC6 bound only weakly, and loaded with substoichiometric amounts of endogenous
CDH1 (Figures 1B and 3G), this cobinding could be me-the subunit CDC26, also present in these fractions,
showed no binding at all. Conversely, APC3 and APC7 diated by dimerization of APC. Alternatively, more than
one receptor for IR tails could be present per complex.were again significantly retained by the CDH1 peptide
matrix (Figure 5B), confirming the results obtained with
recombinant proteins (Figure 5A). Interestingly, APC3 C-Terminal Peptides of CDH1 and CDC20
Inhibit APC Activationand APC7 are highly related in their primary sequences.
In budding yeast, which lacks a gene for APC7, both Our results so far suggested that the interaction of IR
tails in CDH1 and CDC20 with TPR subunits might facili-proteins share Cdc27 as their closest homolog [29]. This
suggests that APC3 and APC7 might have originated tate recruitment of the activators to the APC. To test
this hypothesis, we analyzed if IR tail peptides couldfrom gene duplication and might still have similar or
overlapping functions. compete for CDH1 binding to the APC and thereby pre-
vent APC activation. Immunopurified APC was loadedLastly, we wanted to know if CDH1’s C terminus would
be sufficient to interact with holo-APC. For this, we incu- with recombinant CDH1 in the presence or absence of
IR tail or control peptides, washed, and used to ubiquiti-bated APC-containing fractions with the peptide matrix.
All subunits were strongly enriched on the CDH1 peptide nate a radioactively labeled fragment of cyclin B. The
C-terminal peptides of CDH1 and CDC20 both blockedmatrix, but not on control peptides (Figure 5C). Since
APC6 and CDC26 from late-eluting fractions did not APC activation efficiently, lowering ubiquitination activ-
ity to almost the level of APC that has not been activatedbind the CDH1 peptide by themselves (Figure 5B), this
indicated that holo-APC can bind to an IR motif peptide. by exogenous CDH1. In contrast, a peptide from the
N-terminal region of CDC20 had no effect on APC activa-Surprisingly, endogenous CDH1 was also enriched on
the peptide matrix (Figure 5C). Since purified APC is tion (Figure 6A). Quantitative immunoblotting with anti-
Molecular Interactions between the APC and CDH1
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Figure 7. Binding and Activation of the APC
Depends on CDH1’s C-Terminal IR Motif and
the C Box
(A) CDH1 binding assay. APC3 IPs from
APC-containing fractions or APC-free control
fractions were incubated with insect cell ly-
sates containing recombinant wild-type CDH1
or CDH1 mutated in the C box (CB), the IR
motif (IR), or in both motifs (2x).
(B) An in vitro ubiquitination assay. APC was
incubated with wild-type or mutant CDH1 as
described above and was used in a ubiquiti-
nation assay with recombinant securin as
substrate.
bodies against APC2 and CDH1 showed that the de- possible to reconstitute the APC from recombinant sub-
units. We have thus searched for subcomplexes derivedcreased activity corresponded with diminished binding
of exogenous CDH1 (Figure 6B). As in the peptide bind- from native human APC and correlated their subunit
composition with their functional properties. This re-ing assays (Figure 5), CDH1’s C-terminal peptide had a
stronger effect than the one from CDC20. The observed verse approach has yielded insights into both ubiquiti-
nation and substrate recognition by the APC.inhibition of CDH1 loading supports the notion that IR
tail binding sites on the APC are required for CDH1
binding. Implications for the APC-Mediated
Ubiquitination Reaction
The RING finger protein APC11 and its binding partner,CDH1 Binding and APC Activation Depend
on Two Motifs in CDH1 the cullin homolog APC2, are able to assemble multiubi-
quitin chains ([4, 7, 8], Figure 2B). Our biochemical analy-Having established that C-terminal IR tails are sufficient
to interact with the APC and interfere with its activation, sis of the 2/11-APC subcomplex has extended these
observations by showing that APC2 and APC11 are notwe wanted to know how their loss would influence CDH1
activity. To this end, we generated a baculovirus encod- only sufficient for ubiquitination reactions in vitro, but
are also strictly required for the activity of holo-APCing CDH1 with a deletion of the C-terminal dipeptide
(IR). Another conserved motif located in CDH1’s (Figure 1C). In addition, crosslinking of UBCx indicates
that APC2 is not only able to bind UBCx in vitro [8], butN-terminal region, the C box, has been shown to be
required for APC binding in yeast [23]. We therefore also that it is also the only major UBCx-crosslinked subunit
in the context of holo-APC and Q350-APC (Figure 3F).generated CDH1 versions with mutations in the C box
(CB) and in both motifs (2x). After expression in insect Since APC11 and, to some extent, APC2/11 hetero-
dimers are able to ubiquitinate APC substrates ([4, 7,cells, we incubated the lysates with antibody bound
APC or control antibody beads, washed, and tested 8], Figure 2B), whereas Q350-APC subcomplexes are not
(Figure 3D), it is possible that part of APC11’s activityfor binding of recombinant CDH1 and APC activation.
Figure 7A shows that both mutations in the C box and is due to an ability to freely interact with substrates,
while the presence of additional subunits (e.g., APC1,in the IR tail diminished binding significantly but not
completely. Combining both mutations resulted in a fur- APC4, APC5 in Q350-APC) might restrain these interac-
tions. Apparently, the competence of subcomplexesther decrease in binding, indicating that C box and IR
tails cooperate to achieve optimal APC binding (Fig- containing APC11 (APC2/11, Q350-APC) to recruit E2 en-
zymes and assemble polyubiquitin chains is not suffi-ure 7A).
Similar, but not identical, effects were seen in sub- cient for substrate ubiquitination. In the context of a
larger APC assembly, substrate recruitment hencestrate ubiquitination assays. While the IR tail deletion
mutant retained some activity, the C box mutant was seems to strictly depend on the presence of specificity
factors like CDH1 and CDC20.almost completely inactive, even though it bound to
APC in higher amounts (Figure 7B). Taken together,
these data argue that both the C box and the IR tail are TPR Subunits and APC Interactions
required for optimal CDH1 binding to the APC and APC with Substrate Specificity Factors
activation. Binding of CDH1 to the APC is independent of the cata-
lytic subunits APC2/APC11. On the other hand, the abil-
ity of CDH1 to bind to APC subcomplexes coincidesDiscussion
with the presence of TPR subunits (Figures 1B and 3G).
Moreover, peptides mimicking the C terminus of CDH1Despite the APC’s essential role in progression through
mitosis in presumably all eukaryotes, we still have a and CDC20, which are essential for APC activation (see
below), can bind to the TPR domain proteins APC3 andvery limited understanding of the functions of its many
subunits and about how they interact with the essential APC7 (Figures 5A and 5B). A role for these subunits in
activator binding is further backed by a recent findingAPC activator proteins CDC20 and CDH1. This lack of
insight is partly due to the fact that it has not been from budding yeast APC lacking the yeast-specific sub-
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unit Apc9. Thisapc9-APC has reduced levels of Cdc27,
the common closest yeast homolog of APC3 and APC7,
and is compromised in its ability to bind Cdh1 [12].
The notion that APC3 and APC7 are receptors for
CDH1’s C terminus is supported by the prediction of
structural homology to the peptide binding protein PEX5
and by the identification of a conserved motif, the IR
tail, in the C terminus of CDH1 and CDC20 that is shared
with APC10. Truncations of APC10’s IR tail abolish bind-
ing to APC3 [9], and similarly, truncation of this motif
in CDH1 strongly reduces CDH1’s ability to bind and
activate APC in vitro (Figure 7). Moreover, peptides con-
taining this motif are sufficient to compete for CDH1
binding to the APC and can thereby prevent APC activa-
tion (Figure 6). The importance of the C terminus of
CDH1 is bolstered by previous findings that C-terminally
tagged budding yeast Cdh1 is nonfunctional and unable
to interact with the APC [23, 30]. During preparation of
this manuscript, Passmore et al. [12] furthermore re-
ported that deletion or mutation of the IR tail in yeast Figure 8. Cartoon Summarizing Our Current Views of APC Assembly
Cdh1 or Cdc20 abolishes APC binding and activation and Mechanism
in vitro. APC2/11 recruit ubiquitin-loaded E2, and they can be dissociated
While all these results support a role for the free IR from the complex. They can also form a stable complex together
with APC1, 4, and 5 in the absence of other subunits, especially thetail in APC binding and activation, Jaspersen et al. [31]
TPR proteins. CDH1 interacts with the TPR subunits APC3 andhave shown that, in vitro, a C-terminal hexahistidine tag
APC7 and might thereby be juxtaposed to APC2/11. This model ison yeast Cdh1 does not interfere with APC activation.
consistent with CDH1’s proposed role as a substrate-presenting
A His tag may be too small to prevent the association factor.
of CDH1 with the APC, although this would argue against
the type of interaction modeled in Figure 4A. Besides,
Kallio et al. [32] reported that CDC20 tagged with the
present in more than one copy within holo-APC ([36],much larger GFP at the C terminus can coprecipitate
C.G. and H.C.V., unpublished data). A computationalwith two APC subunits, although the functionality of this
search (“Evoluation,” see the Supplemental Data for a
interaction has not been tested. It is therefore conceiv-
brief description) for proteins with C-terminal IR motifs
able that the C box, another APC interaction motif pre-
identified several more candidates, among them the ubi-
viously identified in CDC20 and CDH1 ([23], Figure 7),
quitin-activating enzyme E1 and the cell-cycle phospha-
was sufficient in these cases to allow APC association. tase CDC14B.
Detailed structural studies will be required to analyze TPRs are the most common sequence motifs identi-
how exactly CDC20 and CDH1 interact with TPR sub- fied in APC subunits so far, being present in contiguous
units of the APC. blocks of six or more repeats in at least four subunits
Interestingly, CDH1 and APC10 share the IR tail, are of the vertebrate APC. In yeast, all TPR subunits are
both only found in substrate recognition-competent essential for viability, and mutations in their genes have
subcomplexes containing TPR subunits, and have both frequently been picked up in screens for temperature-
been implicated in substrate binding [12, 22]. It is there- sensitive cell division cycle (cdc) mutants, underscoring
fore conceivable that CDH1 first recruits substrates to the important role of these proteins in mitotic progres-
the APC, whereas APC10 helps to sequester substrates sion [13, 18, 37–41]. Nonetheless, apart from the notion
during the elongation of ubiquitin chains [11, 12]. The of a general role in mediating protein-protein interac-
DOC domain in APC10, which is also found in other tions, their precise functions within the APC had re-
ubiquitin ligases [33–35] and is likely to coordinate an mained enigmatic. For two of these subunits, APC3 and
unidentified ligand [9, 10], may have an important role ACP7, our observations now indicate an important role
in this substrate binding and positioning reaction. in activator binding through an extended peptide. Nota-
bly, two amino acid exchanges in described APC3-TPR
domain mutants of different species [42, 43] are pre-
Is Modularity the Reason for the dicted by our structural model to be in close proximity
APC’s Complexity? of the C-terminal arginine residue of the IR peptide (data
Both CDC20/CDH1 and APC10 appear to bind APC not shown).
through the same conserved C-terminal motif, and en- TPR domain interactions with C-terminal peptide mo-
dogenous CDH1 is furthermore found associated with tifs have been described for the peroxisomal targeting
APC bound to an IR peptide (Figure 5C). This makes it signal PTS1 and its receptor PEX5 [15, 26], and for the
likely that there are multiple binding sites for IR tails. C termini of Hsp70/Hsp90 and several interacting TPR
Our data are consistent with this possibility, since both proteins like Hop [44, 45]. APC3 and APC7 appear to
APC3 and APC7 interact with IR peptides in vitro (Fig- represent a third class of TPR proteins that bind inter-
acting proteins via their C termini. Since the predictedures 5A and 5B). In addition, each TPR subunit may be
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spectrometric analysis of the anaphase-promoting complexstructures of APC6 and APC8 also match PEX5 (Table
from yeast: identification of a subunit related to cullins. ScienceS1), it is tempting to speculate that they too might share
279, 1216–1219.this property. In this way, the TPR subunits could serve
7. Leverson, J.D., Joazeiro, C.A., Page, A.M., Huang, H., Hieter,
as versatile adaptor sites for a variety of interacting P., and Hunter, T. (2000). The APC11 RING-H2 finger mediates
proteins and thus rationalize some of the APC’s com- E2-dependent ubiquitination. Mol. Biol. Cell 11, 2315–2325.
8. Tang, Z., Li, B., Bharadwaj, R., Zhu, H., Ozkan, E., Hakala, K.,plexity.
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